Skip to main content
SpringerLink
Log in

Epidemiology: Extent of the Problem

  • Chapter
Treatment of Peritoneal Surface Malignancies

Part of the book series: Updates in Surgery ((UPDATESSURG))

  • 892 Accesses

Abstract

Peritoneal carcinomatosis (PC) most commonly represents local or regional evolution of an abdominal carcinoma. Sometimes it can be synchronous with the primary tumor (primary carcinomatosis) but more often is present as recurrent disease (metachronous or secondary) after first-line treatment of the originating tumor. Patients with tumors from colon, ovary, and stomach cancer are more likely to present with PC during their clinical course. Less frequently, other abdominal malignancies, such as uterus, pancreas, small bowel, biliary, or urinary tract, can involve the peritoneum. Tumors originating from the peritoneum itself are definitely rarer: mesothelioma, pseudomyxoma peritonei (PMP), primitive peritoneal carcinoma, and desmoplastic small-round-cell tumor. PC from extra-abdominal tumors, such as lung, breast, melanoma, or peritoneal sarcomatosis, is exceptional, and few epidemiological data are available on them. Statistical analysis of worldwide cancer incidence, prevalence, and mortality rate is available on GLOBOCAN 2012 [1]. In Italy, most epidemiological data are available in the reports from the Italian Association of Tumor Registries (AIRTUM) [2], which collects data regarding incidence, prevalence, and mortality rates from all local and regional tumor registries, covering at least 34% of total population. This data is considered a high-quality regional coverage by and international ranking system (GLOBOCAN 2012 rate B).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. WHO GLOBOCAN 2012— Section of cancer information www.iarc.fr

    Google Scholar 

  2. Airtum Working Group (2001) La sopravvivenza dei pazienti oncologici in Italia. Epidemiologia e Prevenzione 35:5–6

    Google Scholar 

  3. Weir HKI, Thun MJ, Hankey BF et al (2003) Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95:1276–1299

    Article  PubMed  Google Scholar 

  4. Koppe MJI, Boerman OC, Oyen WJ, Bleichrodt RP (2006) Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 243:212–222

    Article  PubMed Central  PubMed  Google Scholar 

  5. Thomassen I, van Gestel YR, Lemmens VE, de Hingh IH (2013) Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin. Dis Colon Rectum 56:1373–1380

    Article  PubMed  Google Scholar 

  6. Cass AW, Million RR, Pfaff WW (1976) Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 37:2861–2865

    Article  CAS  PubMed  Google Scholar 

  7. Eisenberg B, Decosse JJ, Harford F et al (1982) Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients. Cancer 49:1131–1134

    Article  CAS  PubMed  Google Scholar 

  8. Gilbert JM, Jeffrey I, Evans M et al (1984) Sites of recurrent tumour after ‘curative’ colorectal surgery: implications for adjuvant therapy. Br J Surg 71:203–205

    Article  CAS  PubMed  Google Scholar 

  9. Malcolm AW, Perencevich NP, Olson RM et al (1981) Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum. Surg Gynecol Obstet 152:131–136

    CAS  PubMed  Google Scholar 

  10. Mendenhall WM, Million RR, Pfaff WW (1983) Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: implications in treatment planning with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 9:977–985

    Article  CAS  PubMed  Google Scholar 

  11. Minsky BD, Mies C, Recht A et al (1988) Resectable adenocarcinoma of the rectosigmoid and rectum: I. Patterns of failure and survival. Cancer 61:1408–1416

    Article  CAS  PubMed  Google Scholar 

  12. Olson RM, Perencevich NP, Malcolm AW et al (1980) Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer 45:2969–2974

    Article  CAS  PubMed  Google Scholar 

  13. Russell AH, Tong D, Dawson LE et al (1984) Adenocarcinoma of the proximal colon: sites of initial dissemination and patterns of recurrence following surgery alone. Cancer 53:360–367

    Article  CAS  PubMed  Google Scholar 

  14. Gunderson LL, Sosin H, Levitt S. (1985) Extrapelvic colon areas of failure in a reoperation series: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 11:731–741

    Article  CAS  PubMed  Google Scholar 

  15. Tong D, Russell AH, Dawson LE et al (1983) Second laparotomy for proximal colon cancer: sites of recurrence and implications for adjuvant therapy. Am J Surg 145:382–386

    Article  CAS  PubMed  Google Scholar 

  16. Russell AH, Pelton J, Reheis CE et al (1985) Adenocarcinoma of the colon: an autopsy study with implications for new therapeutic strategies. Cancer 56:1446–1451

    Article  CAS  PubMed  Google Scholar 

  17. Jayne DG, Fook S, Loi C et al (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545–1550

    Article  CAS  PubMed  Google Scholar 

  18. Goéré D, Gras-Chaput N, Aupérin A, Flament C (2014) Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab. BMC Cancer 14:148

    Article  PubMed Central  PubMed  Google Scholar 

  19. Nissan A, Garofalo A, Esquivel J (2010) Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) for gastric adenocarcinoma: why haven’t we reached the promised land? J Surg Oncol 102:359–360

    Article  PubMed  Google Scholar 

  20. European Union Network of Excellence (EUNE) for Gastric Cancer Steering Group (2008) astric cancer in Europe. Br J Surg 95:406–408

    Article  Google Scholar 

  21. Hioki M, Gotohda N, Konishi M et al (2010) Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis. World J Surg 34:555–562

    Article  PubMed  Google Scholar 

  22. Gunderson LL, Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8:1–11

    Article  CAS  PubMed  Google Scholar 

  23. Roviello F, Marrelli D, de Manzoni G et al (2003) Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90:1113–1139

    Article  CAS  PubMed  Google Scholar 

  24. Marrelli D et al; Italian Research Group for Gastric Cancer (2011) Changing clinical and pathological features of gastric cancer over time. Br J Surg 98:1273–1283

    Article  CAS  PubMed  Google Scholar 

  25. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  26. Prat J, Ribé A, Gallardo A (2005) Hereditary ovarian cancer. Hum Pathol 36:861–870

    Article  CAS  PubMed  Google Scholar 

  27. Surveillance, Epidemiology and End Results (SEER) program. SEER stat Database: Incidence- SEER 9 Regs Public Use. Nov 2003, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, April 2004 (http://www.seer.cancer.gov)

    Google Scholar 

  28. Peterson CE, Rauscher GH, Johnson TP et al (2014) The association between neighborhood socio-economic status and ovarian cancer tumor characteristics. Cancer Causes Control 25:633–637

    Article  PubMed  Google Scholar 

  29. Bristow RE, Chang J, Ziogas A et al (2014) High-volume ovarian cancer care: Survival impact and disparities in access for advanced-stage disease. Gynecol Oncol 132:403–410

    Article  PubMed  Google Scholar 

  30. European Network of Cancer Registries. Eurocim version 4.0. European incidence database V2.3, C15 Dictionary (2001). Lyon, France: IARC 2001

    Google Scholar 

  31. Boffetta P (2007) Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 18:985–990

    Article  CAS  PubMed  Google Scholar 

  32. Peto J, Hodgson JT, Matthews FE, Jones JR (1995) Continuing increase in mesothelioma mortality in Britain. Lancet 345:535–539

    Article  CAS  PubMed  Google Scholar 

  33. Mirabelli D, Roberti S, Gangemi M et al (2009) Survival of peritoneal malignant mesothelioma in Italy: a population-based study. Int J Cancer 124:194–200

    Article  CAS  PubMed  Google Scholar 

  34. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA (2008) Appendiceal neoplasms and pseudomyxoma peritonei: a population-based study. Eur J Surg Oncol 34:196–201

    Article  CAS  PubMed  Google Scholar 

  35. Andréasson HI, Graf W, Nygren P et al (2012) Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei. Eur J Surg Oncol 38:962–968

    Article  PubMed  Google Scholar 

  36. Sherer DMI, Abulafia O, Eliakim R (2001) Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest 51:73–80

    Article  CAS  PubMed  Google Scholar 

  37. Thomassen I, Lemmens VE, Nienhuijs SW et al (2013) Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study. Pancreas 42:72–75

    Article  PubMed  Google Scholar 

  38. Tuthill M, Pell R, Giuliani R et al (2009) Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis. Eur J Cancer 45:2146

    Article  PubMed  Google Scholar 

  39. Sereno M, Rodríguez-Esteban I, Gómez-Raposo et al (2013) Lung cancer and peritoneal carcinomatosis. Oncol Lett 6:705–708

    PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery “Pietro Valdoni”, Sapienza University of Rome, Rome, Italy

    Simone Sibio

Authors
  1. Simone Sibio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph Maher Fouad Atta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessio Impagnatiello
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bianca Maria Sollazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniele Marrelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simone Sibio .

Editor information

Editors and Affiliations

  1. Department of Surgery “Pietro Valdoni”, Sapienza University of Rome, Rome, Italy

    Angelo Di Giorgio

  2. Department of Medical, Surgical, and Neurological Sciences, University of Siena, Siena, Italy

    Enrico Pinto

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Italia

About this chapter

Cite this chapter

Sibio, S., Atta, J.M.F., Impagnatiello, A., Sollazzo, B.M., Marrelli, D. (2015). Epidemiology: Extent of the Problem. In: Di Giorgio, A., Pinto, E. (eds) Treatment of Peritoneal Surface Malignancies. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5711-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5711-1_2

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5710-4

  • Online ISBN: 978-88-470-5711-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation